Canadian Intellitab Patents

Montreal, Quebec, Canada

Altus Formulation Inc. a Quebec – based drug formulation and development company, leveraging it’s patented drug delivery technologies to develop Safer to UseTM formulations for its partners and their patients today announced the issuance of two new Canadian patents covering the company’s proprietary INTELLITABTM  Misuse and Abuse Deterrent Technology; the patents issued were;

 

Canadian Patent No. 2,707,980
Title: MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

and;

Canadian Patent No. 2,746,888

Title:     MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

 

Damon Smith, CEO Altus Formulation commented; ‘These new patents, complementing those granted in the USA, Europe and Japan, strengthen and extend our patent portfolio and we look forward to discussions with potential licensees’.

 

About INTELLITABTM

INTELLITABTM  technology is a novel drug delivery platform suitable for twelve or twenty four hour extended release formulations of one or more drugs that mitigates the misuse and abuse potential of narcotic and stimulant tablets. INTELLITABTM tablets display the following unique features;

  • Tablets are ultra-hard to resist crushing, chewing and grinding.
    · Tablets resist alcohol and other solvents
    · Tablets may be broken with no loss of controlled release.
    · Crushed tablets retain controlled release properties after ingestion.
    · Ground tablets absorb liquids to form gels to resist injection and defeat insufflation (snorting)
    · INTELLITABTM are made using well established manufacturing processes and contain no aversive or antagonist agents unneeded and potentially hazardous to patients. First do No Harm

To coincide with the granting of these important patents Altus is seeking co-development and commercialization agreements with Canadian companies seeking to lead the way in abuse deterrent formulation commercialization in this country.

 

 

For more information please contact.
Damon Smith
CEO Altus Formulation
dsmith@altusformulation.com
tel: (1) 514 883 3447